AVALO THERAPEUTICS, INC. (AVTX) Gross profit 2016–2023
AVALO THERAPEUTICS, INC. (AVTX) annual gross profit history from SEC filings — each fiscal year as reported.
$640,000FY2023 · since FY2016: $1.2M → $640,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $640,000 | -95.6% |
| FY2022 | $14.6M | +274.1% |
| FY2021 | $3.9M | -38.9% |
| FY2020 | $6.4M | -12.5% |
| FY2019 | $7.3M | +94.2% |
| FY2018 | $3.8M | -86.1% |
| FY2017 | $27.2M | +2257.1% |
| FY2016 | $1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice